{
    "Trade/Device Name(s)": [
        "Fenom Pro"
    ],
    "Submitter Information": "CAIRE Diagnostics Inc.",
    "510(k) Number": "K213611",
    "Predicate Device Reference 510(k) Number(s)": [
        "K182874"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MXA"
    ],
    "Summary Letter Date": "June 7, 2023",
    "Summary Letter Received Date": "November 2, 2022",
    "Submission Date": "November 1, 2022",
    "Regulation Number(s)": [
        "21 CFR 862.3080"
    ],
    "Regulation Name(s)": [
        "Breath Nitric Oxide Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Fractional exhaled nitric oxide (FENO)"
    ],
    "Specimen Type(s)": [
        "Expired human breath"
    ],
    "Specimen Container(s)": [
        "Disposable mouthpiece"
    ],
    "Instrument(s)/Platform(s)": [
        "Fenom Pro device"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric sensor technology"
    ],
    "Methodologies": [
        "Quantitative measurement of exhaled nitric oxide"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument",
        "Point-of-care"
    ],
    "Document Summary": "FDA 510(k) summary for Fenom Pro portable point-of-care device for non-invasive measurement of fractional exhaled nitric oxide in human breath",
    "Indications for Use Summary": "Adjunct device for point-of-care measurement of fractional exhaled nitric oxide in adults and children 6+ years to monitor response to anti-inflammatory therapy in asthma and airway inflammatory conditions",
    "fda_folder": "Toxicology"
}